Test Code SFX Protein S Activity, Plasma
Specimen Required
Specimen Type: Platelet-poor plasma
Patient Preparation: Patient must not be receiving Coumadin.
Collection Container/Tube: Light-blue top (3.2% sodium citrate)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. For complete instructions, see Coagulation Guidelines for Specimen Handling and Processing
2. Centrifuge, transfer all plasma into a plastic vial, and centrifuge plasma again.
3. Aliquot plasma into a plastic vial leaving 0.25 mL in the bottom of centrifuged vial.
4. Freeze specimen immediately (no longer than 4 hours after collection) below -40° C.
Useful For
Second-order testing for diagnosis of congenital or acquired protein S deficiency, ie, as an adjunct to initial testing based on results of protein S antigen assay (free protein S antigen, with or without total protein S antigen assay)
Evaluating patients with a history of venous thromboembolism
Special Instructions
Method Name
Optical Clot-Based
Reporting Name
Protein S Activity, PSpecimen Type
Plasma Na CitSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Na Cit | Frozen | 14 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Reference Values
Males: 65-150%
Females
<50 years: 50-150%
≥50 years: 65-150%
Newborn infants have normal or near-normal free protein S antigen (≥50%), although total protein S antigen is usually below the adult reference range. There are insufficient data concerning protein S activity in normal neonates, infants, and children; but normal or near-normal activity (≥50%) probably is present by age 3 to 6 months.
Interpretation
In type I and type III congenital deficiency, free protein S antigen is decreased, and protein S functional activity is similarly decreased. In type II congenital (dysfunctional) protein S deficiency, total and free protein S antigen levels are normal, but functional activity is decreased.
Patients with acquired free protein S deficiency associated with inflammation-related increase of C4b-binding protein typically have decreased free protein S antigen and protein S activity with normal (or elevated) total protein S antigen. Acquired protein S deficiency is of uncertain clinical hemostatic significance and is associated with a variety of conditions.
Elevated protein S levels are of uncertain clinical significance.
Day(s) Performed
Monday through Friday
Report Available
1 to 4 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
85306
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
SFX | Protein S Activity, P | 27822-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
SFX | Protein S Activity, P | 27822-6 |
Forms
If not ordering electronically, complete, print, and send an Coagulation Test Request (T753) with the specimen.